A New Kind of Vaccine Offers Hope for Surviving Pancreatic Cancer

Cancer research is edging into a new frontier, and scientists say one of its most promising tools is something most of us first met during the pandemic: mRNA vaccines. Long before they helped fend off COVID-19, researchers were exploring how this technology might teach the immune system to recognize and attack cancers that have long resisted treatment. A new report from Scientific American explores that shift, the early signs of hope, and the growing worries that political headwinds could slow lifesaving breakthroughs. Scientific American has the story that was compiled by multiple authors.

Kendra Pierre-Louis, Rowan Moore Gerety, Fonda Mwangi, Alex Sugiura & Jeffery DelViscio

Scientific American

View Source